Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Pediatr Emerg Care. 2021 Dec 23;38(9):e1564–e1568. doi: 10.1097/PEC.0000000000002608

Table 1.

Distribution of demographics, tests, treatments and disposition of patients with bronchiolitis among nurse practitioners and physicians in the pediatric emergency department.

Variable Total
(N=5,260)
n (%)
Nurse practitioner
(N=1,598)
n (%)
Physician
(N=3,435)
n (%)
Both
(N=227)
n (%)
P-value
Age group (months)
 1–3 581 (11) 59 (4) 489 (14) 33 (15) <0.001
 4–12 2593 (49) 845 (53) 1633 (48) 115 (51)
 13–24 2086 (40) 694 (43) 1313 (38) 79 (35)
Diagnostic test
 Chest radiography 1959 (37) 588 (37) 1259 (37) 112 (49) 0.001
 Viral testing 1145 (22) 350 (22) 739 (22) 56 (25) 0.530
 RSV test 1020 (19) 205 (13) 762 (22) 53 (23) <0.001
Treatment
 Bronchodilator 2970 (57) 874 (55) 1943 (57) 153 (67) 0.001
 Corticosteroid 1013 (19) 147 (9) 812 (24) 54 (24) <0.001
 Antibiotics 455 (9) 123 (8) 305 (9) 27 (12) 0.079
Any ToT 3284 (80) 946 (80) 2158 (80) 180 (86) 0.105
Total ToT* 2 (1–3) 1 (1–2) 2 (1–3) 1 (1–3) <0.001
Disposition
 Admission 1178 (22) 25 (2) 1072 (31) 81 (36) <0.001
 Discharge 4070 (77) 1571 (98) 2353 (69) 146 (64)
LOS (minutes)* 144 (91–206) 137 (105–170) 149 (61–226) 182 (93–285) <0.001

RSV=Respiratory syncytial virus; LOS=Length of stay; ToT=test or treatment

*

Median (interquartile range [Q1–Q3])